Bookbuilding IPO | ₹111 Cr | Listing at BSE, NSE | Wed, Nov 9, 2016 - Tue, Nov 22, 2016
GreenSignal Bio Pharma IPO is a book build issue of ₹110.80 crores. The issue is entirely an offer for sale of 1.46 crore shares of ₹110.80 crore.
GreenSignal Bio Pharma IPO bidding started from Nov 9, 2016 and ended on Nov 22, 2016. The allotment for GreenSignal Bio Pharma IPO was finalized on Nov 18, 2016. GreenSignal Bio Pharma IPO will list on NSE and BSE with a tentative listing date fixed as Nov 22, 2016.
GreenSignal Bio Pharma IPO is set issue price band at ₹68 to ₹76 per share. The lot size for an application is 175 shares. The minimum amount of investment required by an individual investor (retail) is ₹13,300 (175 shares) (based on upper price). The lot size investment for sNII is 16 lots (2,800 shares), amounting to ₹2,12,800, and for bNII, it is 76 lots (13,300 shares), amounting to ₹10,10,800.
Indian Overseas Bank is the book running lead manager and Bigshare Services Pvt.Ltd. is the registrar of the issue.
Refer to GreenSignal Bio Pharma IPO RHP for detailed Information.
IPO Open
Wed, Nov 9, 2016
IPO Close
Tue, Nov 22, 2016
Price Band
₹68 to ₹76
Market Cap (Pre-IPO)
To be declared
| IPO Date | 9 to 22 Nov, 2016 |
| Listing Date | Tue, Nov 22, 2016T |
| Face Value | ₹10 per share |
| Price Band | ₹68 to ₹76 |
| Lot Size | 175 Shares |
| Sale Type | OFS only |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE, NSE |
| Total Issue Size | 1,45,79,560 shares (agg. up to ₹111 Cr) |
| Offer for Sale | 1,45,79,560 shares of ₹10 (agg. up to ₹111 Cr) |
| Share Holding Pre Issue | 38,36,72,750 shares |
| Share Holding Post Issue | 38,36,72,750 shares |
GreenSignal Bio Pharma IPO comprises a total issue size of 1,45,79,560 shares. Out of which, 1,09,34,670 are allocated to QIB, 21,86,934 (15.00%) allocated to NII 14,57,956 (10.00%) allocated to RII.
| Investor Category | Shares Offered | % of Total Issue | Max Allottees |
|---|---|---|---|
| QIB Shares Offered | 1,09,34,670 | NA | |
| − QIB (Ex. Anchor) Shares Offered | 1,09,34,670 | NA | |
| NII (HNI) Shares Offered | 21,86,934 | 15.00% | NA |
| Retail Shares Offered | 14,57,956 | 10.00% | 8,331 |
| Total Shares Offered | 1,45,79,560 | 100.00% |
Investors can bid for a minimum of 175 shares and in multiples thereof.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 175 | ₹13,300 |
| Retail (Max) | 15 | 2,625 | ₹1,99,500 |
| S-HNI (Min) | 16 | 2,800 | ₹2,12,800 |
| S-HNI (Max) | 75 | 13,125 | ₹9,97,500 |
| B-HNI (Min) | 76 | 13,300 | ₹10,10,800 |
Incorporated in 2005, GreenSignal Bio Pharma is Chennai based pharmaceutical company engaged in the development, manufacture and sale of the BCG vaccine. source chittorgarh.com, India's No. 1 IPO Investment Portal. GreenSignal is an Indian vaccine manufacturing company with global operations. The products company manufacture includes a BCG vaccine and BCG-ONCO, an immunotherapy drug. The immunotherapy drug is used in the treatment of urinary bladder cancer.
Both vaccines produced by GreenSignal are generic drugs and company do not require any patents for the same.
GreenSignal has a long term contract with UNICEF to supply the BCG vaccine to UNICEF. GreenSignal is among 4 companies worldwide who have been WHO-prequalified to supply the BCG vaccine to UNICEF. Other customers include Indonesia, Nepal and Ministry of Health, India.
GreenSignal Pharma business is organized into domestic and international operations. For FY 2016, GreenSignal's domestic and international operations accounted for 53.79% and 46.20%, respectively, of its net revenues from operations. Visit chittorgarh.com for more detail.
GreenSignal Bio have a manufacturing facility located at Pappankuppam Village, Gummidipoondi, Tiruvallur District, Tamil Nadu.
| Company | Issue Type | Issue Size | Issue Price | PE Ratio | Listing Day Close | Listing Gain/Loss % | LTP |
|---|---|---|---|---|---|---|---|
| Alkem Laboratories Ltd. | Mainboard | ₹1,347.76 Cr | ₹1050 | null | ₹1,381.70 | +31.59% | ₹5,709.00 (+0.64%) |
| Sakar Healthcare Ltd. | SME | ₹14.81 Cr | ₹50 | null | ₹52.15 | +4.30% | ₹896.95 (-2.18%) |
| Kwality Pharmaceuticals Ltd. | SME | ₹6.21 Cr | ₹45 | null | ₹44.50 | -1.11% | ₹2,816.90 (+3.80%) |
| Bajaj Healthcare Ltd. | SME | ₹30.90 Cr | ₹170 | null | ₹171.50 | +0.88% | ₹372.90 (+2.15%) |
| Ganga Pharmaceuticals Ltd. | SME | ₹1.54 Cr | ₹15 | null | ₹14.50 | -3.33% | ₹12.00 (+0.00%) |
The GreenSignal Bio Pharma IPO IPO subscription status. Full data available on IPOMatrix.com.
| Category | Subscription (times) | Shares Offered | Shares bid for | |
|---|---|---|---|---|
| Total | - | - | - | |
| # | Issue Expenses | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Book Running Lead Manager(including underwriting commission, brokerage and selling commission) | |
| 2 | Commission And Processing Fee For SCSBs And Bankers to the Offer | |
| 3 | Brokerage and Selling commission for Registered Brokers, RTA‘s and CDPs etc. | |
| 4 | Fees to Registrar and Share Transfer Agent to the Offer | |
| 5 | Legal Counsels to the Offer | |
| 6 | Other advisors to the Offer | |
| 7 | Bankers to the Offer | |
| 8 | Other Expenditure –Listing Fees, Printing & Stationery expenses, Advertising, Marketing etc |
Book Running Lead Managers to the GreenSignal Bio Pharma Limited, has informed the Exchange that according to 26 (2) of SEBI (ICDR) Regulations, if 75% of the net offer to public cannot be allotted to QIBs, the entire application money shall be refunded forthwith. Hence, the IPO of GreenSignal Bio Pharama Limited may be treated as withdrawn.
Book Running Lead Managers to the GreenSignal Bio Pharma Limited, has informed the Exchange that the issue closure date has been further extended upto 22 Nov,2016. Post issue modification date has been revised to 23 Nov,2016. Price band has been revised to Rs 68/- to Rs 76/-
Book Running Lead Managers to the GreenSignal Bio Pharma Limited, has informed the Exchange that the issue closure date has been extended upto 17 Nov,2016. Post issue modification date has been revised to 18 Nov,2016.
Lead Manager Reports
GreenSignal Bio Pharma IPO is a main-board IPO of 1,45,79,560 equity shares of the face value of ₹10 aggregating up to ₹111 Crores. The issue is priced at ₹68 to ₹76. The minimum order quantity is 175.
The IPO opens on Wed, Nov 9, 2016, and closes on Tue, Nov 22, 2016.
Bigshare Services Pvt.Ltd. is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.
Zerodha customers can apply online in GreenSignal Bio Pharma IPO using UPI as a payment gateway. Zerodha customers can apply in GreenSignal Bio Pharma IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in GreenSignal Bio Pharma IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The GreenSignal Bio Pharma IPO opens on Wed, Nov 9, 2016 and closes on Tue, Nov 22, 2016.
GreenSignal Bio Pharma IPO lot size is 175, and the minimum amount required for application is ₹13,300.
You can apply in GreenSignal Bio Pharma IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.
The finalization of Basis of Allotment for GreenSignal Bio Pharma IPO will be done on Friday, November 18, 2016, and the allotted shares will be credited to your demat account by Mon, Nov 21, 2016. Check the GreenSignal Bio Pharma IPO allotment status.
The GreenSignal Bio Pharma IPO listing date is not yet announced. The tentative date of listing is Tue, Nov 22, 2016.
